Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871

Detalles Bibliográficos
Autores principales: Rodriguez, Emma, Pei, Guangsheng, Zhao, Zhongming, Kim, Sang T., German, Alexis, Robinson, Prema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533910/
https://www.ncbi.nlm.nih.gov/pubmed/34680400
http://dx.doi.org/10.3390/cancers13205178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533910/
https://www.ncbi.nlm.nih.gov/pubmed/34680400
http://dx.doi.org/10.3390/cancers13205178

Ejemplares similares